Norma Carmen
Gutiérrez Gutiérrez
Profesora Asociada CC. Salud
ATANASIO
PANDIELLA ALONSO
Investigador
Publicacions en què col·labora amb ATANASIO PANDIELLA ALONSO (10)
2015
-
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone
Leukemia, Vol. 29, Núm. 3, pp. 705-714
2012
-
CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype
Haematologica, Vol. 97, Núm. 7, pp. 1110-1114
-
Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
Leukemia, Vol. 26, Núm. 8, pp. 1862-1869
2011
-
Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response
Haematologica, Vol. 96, Núm. 5, pp. 687-695
2009
-
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
Leukemia, Vol. 23, Núm. 8, pp. 1515-1527
2006
-
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance
Cancer Research, Vol. 66, Núm. 11, pp. 5781-5789
2005
-
Bortezomib is an efficient agent in plasma cell leukemias
International Journal of Cancer, Vol. 114, Núm. 4, pp. 665-667
-
Genetic abnormalities and patterns of antigenic expression in multiple myeloma
Clinical Cancer Research, Vol. 11, Núm. 10, pp. 3661-3667
-
Multifunctional role of Erk5 in multiple myeloma
Blood, Vol. 105, Núm. 11, pp. 4492-4499
2003
-
Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents
British Journal of Haematology, Vol. 123, Núm. 5, pp. 858-868